Literature DB >> 31258059

Computational and Kinetic Studies of Acetylcholine Esterase Inhibition by Phenserine.

Shams Tabrez1,2, Ghazi A Damanhouri1,2.   

Abstract

BACKGROUND: The inhibition of cholinesterase enzymes is one of the promising strategies to manage several neurological disorders that include Alzheimer's disease (AD).
MATERIAL AND METHODS: In the current article, we estimated the potential inhibition of acetyl cholinesterase (AChE) by phenserine using slightly modified Ellman assay. To find out the binding interactions of phenserine with the catalytic site of AChE, a molecular docking study was also performed.
RESULTS: Phenserine was found to inhibit Electrophorus electricus AChE in a dose-dependent manner with an IC50 value of 0.013 µM. The kinetic analyses indicate that phenserine inhibits AChE in a mixed type manner (competitive and uncompetitive) with Ki values of 0.39 μmole/l and 0.21 µmole/l, respectively. On the other hand, Km and Vmax values were found to be 0.17 µM and 0.39 µM, respectively. The molecular docking studies indicate efficient binding of phenserine through 6 hydrogen bonds, 4 pi-alkyl interactions, and 1 pi-pi interaction within the AChE catalytic pocket.
CONCLUSION: Results of our computational and kinetics studies indicated a mixed type inhibition by phenserine at AChE catalytic site. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Acetylcholine esterase; cholinesterase enzymes; inhibition; kinetics; molecular docking; phenserine.

Mesh:

Substances:

Year:  2019        PMID: 31258059     DOI: 10.2174/1381612825666190618141015

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  The Microbiota-Gut-Brain Axis-Heart Shunt Part II: Prosaic Foods and the Brain-Heart Connection in Alzheimer Disease.

Authors:  Mark Obrenovich; Shams Tabrez; Bushra Siddiqui; Benjamin McCloskey; George Perry
Journal:  Microorganisms       Date:  2020-03-31

2.  Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats.

Authors:  Shanji Nan; Peng Wang; Yizhi Zhang; Jia Fan
Journal:  Drug Des Devel Ther       Date:  2021-05-13       Impact factor: 4.162

3.  Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer's treatment.

Authors:  Nasimudeen R Jabir; Md Tabish Rehman; Khadeejah Alsolami; Shazi Shakil; Torki A Zughaibi; Raed F Alserihi; Mohd Shahnawaz Khan; Mohamed F AlAjmi; Shams Tabrez
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.